Evidence map›Paper›PMID 40593699›Full record

ArticleNature communications2025

Merging the computational design of chimeric type I polyketide synthases with enzymatic pathways for chemical biosynthesis.

Yash Chainani, Jacob Diaz, Margaret Guilarte-Silva, Vincent Blay, Quan Zhang, William Sprague, Keith E J Tyo, Linda J Broadbelt, Aindrila Mukhopadhyay, Jay D Keasling and 2 more

Abstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Yash ChainaniDepartment of Chemical and Biological Engineering, Northwestern University, Evanston, IL, USA.
Jacob DiazJoint BioEnergy Institute, Emeryville, CA, USA.
Margaret Guilarte-SilvaDepartment of Chemical and Biological Engineering, Northwestern University, Evanston, IL, USA.
Vincent BlayJoint BioEnergy Institute, Emeryville, CA, USA.ORCID http://orcid.org/0000-0001-9602-2375
Quan ZhangDepartment of Chemical and Biological Engineering, Northwestern University, Evanston, IL, USA.ORCID http://orcid.org/0000-0002-9094-5686
William SpragueDepartment of Chemical and Biological Engineering, Northwestern University, Evanston, IL, USA.ORCID http://orcid.org/0000-0003-2940-9726
Keith E J TyoDepartment of Chemical and Biological Engineering, Northwestern University, Evanston, IL, USA.ORCID http://orcid.org/0000-0002-2342-0687
Linda J BroadbeltDepartment of Chemical and Biological Engineering, Northwestern University, Evanston, IL, USA.
Aindrila MukhopadhyayJoint BioEnergy Institute, Emeryville, CA, USA.ORCID http://orcid.org/0000-0002-6513-7425
Jay D KeaslingJoint BioEnergy Institute, Emeryville, CA, USA.ORCID http://orcid.org/0000-0003-4170-6088
Hector Garcia MartinJoint BioEnergy Institute, Emeryville, CA, USA.ORCID http://orcid.org/0000-0002-4556-9685
Tyler W H BackmanJoint BioEnergy Institute, Emeryville, CA, USA. tbackman@lbl.gov.ORCID http://orcid.org/0000-0002-6056-353X

Funding

U.S. Department of Energy (DOE) DE-AC02-05CH11231U.S. Department of Energy (DOE) ERCAP0028489
6 · The paper itself

Abstract

Synthetic biology offers the promise of manufacturing chemicals more sustainably than petrochemistry. Yet, both the rate at which biomanufacturing can synthesize these molecules and the net chemical accessible space are limited by existing pathway discovery methods, which can often rely on arduous literature searches. Here, we introduce BioPKS pipeline, an automated retrobiosynthesis tool combining multifunctional type I polyketide synthases (PKSs) and monofunctional enzymes via two complementary tools: RetroTide and DORAnet. Monofunctional enzymes are valuable for carefully decorating a substrate's carbon backbone while PKSs are unique in their ability to iteratively catalyze carbon-carbon bond formation reactions, thereby expanding carbon backbones in a predictable fashion. We evaluate the performance of BioPKS pipeline using a previously reported set of 155 biomanufacturing candidates, achieving exact synthetic designs for 93 compounds and generating chemically similar pathways for most remaining targets. Furthermore, BioPKS pipeline can propose pathways for the complex therapeutic natural products cryptofolione and basidalin.

Indexed as

Polyketide SynthasesSynthetic BiologyBiological ProductsBiosynthetic PathwaysBiological ProductsPolyketide Synthases

Identifiers

PMID40593699
PMCPMC12216248

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.